alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Crop Genetics Research: Stoneville, MS
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    CareersSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Southeast Area Stoneville, Mississippi Crop Genetics Research People & Locations







Christopher  Street
                        Crop Genetics Research

                        




                        
                        Agricultural Science Research Technician
                        Phone: (731) 425-4744
                        
                        
                        Fax: (731) 425-4760(Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Poultry Research: Mississippi State, MS
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    CareersSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Southeast Area Mississippi State, Mississippi Poultry Research People & Locations







Hannah  Morris
                        Poultry Research

                        




                        
                        Animal Caretaker
                        Phone: (662) 320-7614
                        
                        
                        Fax: (Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



         In connection with the Annual Report of Cistera Networks,  Inc. on Form
10-KSB for the period  ending March 31, 2007, as filed with the  Securities  and
Exchange  Commission  on the date  hereof  (the  "Report"),  I, Derek P.  Downs,
President and CEO of the Company,  certify,  pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the  Sarbanes-Oxley  Act of 2002, that, to
the best of my knowledge and belief:

         (1)      the Report fully  complies  with the  requirements  of Section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      the information  contained in the Report fairly  presents,  in
                  all material respects,  the financial  condition and result of
                  operations of the Company.


/s/    Derek P. Downs
Derek P. Downs
President
(Principal Executive Officer)


June 28, 2007


A signed  original of this written  statement  required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the  electronic  version of this written  statement
has been  provided  to the  Company  and will be  retained  by the  Company  and
furnished to the Securities and Exchange Commission or its staff upon request.
<PAGE>

EXHIBIT 11.2

                  VARI-LITE INTERNATIONAL, INC.
             COMPUTATION OF INCOME PER COMMON SHARE
        FOR THE SIX MONTHS ENDED MARCH 31, 1997 AND 1998
            (In thousands except share data)

<TABLE>
                                                              1997         1998 
                                                              ----         ---- 
<S>                                                           <C>          <C>  
Income before extraordinary loss........................     $1,745        $837 

Net income..............................................     $1,745        $100 

Weighted average shares outstanding.....................  5,806,132   7,624,179 

Dilutive effect of stock warrants after application of                          
 treasury stock method..................................     19,473      14,193 

Shares used in calculating diluted income per share.....  5,825,605   7,638,372 

Basic income per share before extraordinary loss........      $0.30       $0.11 

Diluted income per share before extraordinary loss......      $0.30       $0.11 

Basic net income per share..............................      $0.30       $0.01 

Diluted net income per share............................      $0.30       $0.01 

</TABLE>

                                       19
EX-4.5





 Exhibit 4.5 
  





 
 SEE REVERSE FOR IMPORTANT NOTICE REGARDING OWNERSHIP AND 
TRANSFER RESTRICTIONS AND CERTAIN OTHER INFORMATION 
GINKGO BIOWORKS HOLDINGS, INC. 
INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE 
CLASS A COMMON STOCK 
CUSIP 000000 00 0 
SEE REVERSE FOR CERTAIN DEFINITIONS 
THIS CERTIFIES THAT 
IS THE OWNER OF 
FULLY PAID AND NON-ASSESSABLE SHARES OF THE COMMON STOCK, $0.0001 PAR VALUE, OF 
GINKGO
BIOWORKS HOLDINGS, INC. 
Transferable on the books of the Company in Person or by duly authorized attorney, upon surrender of this Certificate properly endorsed.
This certificate and the shares represented hereby, are issued and shall be held subject to all of the provisions of the Certification of Incorporation, as amended, and the Bylaws, as amended, of the Company (copies of which are on file with the
Company and with the Transfer Agent), to all of which each holder, by acceptance hereof, assents. This Certificate is not valid unless countersigned and registered by the Transfer Agent and Registrar. 
WITNESS the facsimile seal of the Company and the facsimile signatures of its duly authorized officers. 
Chief Financial Officer 
Chief Executive Officer 












 



 
 The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were
written out in full according to applicable laws or regulations: 
TEN COM as tenants in common 
TEN ENT as tenants by the entireties 
JT TEN as joint tenants with right of survivorship and
not as tenants in common 
TTEE trustee under Agreement dated 
UNIF GIFT MIN ACT
Custodian 
(Cust) (Minor) 
under Uniform Gifts to Minors 
Act (State) 
Additional abbreviations may also be used though not in the above list.

For value received, hereby sell, assign and transfer unto 
PLEASE INSERT
SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE 
PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS INCLUDING POSTAL ZIP CODE OF ASSIGNEE. 
Shares of the common stock represented by this certificate and do hereby irrevocably constitutes and appoint Attorney, to transfer the said stock on the books of the within-named
Corporation with full 
power of substitution in the premises. 
DATED

NOTICE: The signature to this assignment must correspond with the name as written upon the face of the certificate in every particular without alteration or
enlargement or any change whatsoever. 
SIGNATURE GUARANTEED: 
THE SIGNATURES(S)
SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION, (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM), PURSUANT TO S.E.C. RULE 17Ad-15.
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                       6,862,313
<SECURITIES>                                         0
<RECEIVABLES>                                3,664,409
<ALLOWANCES>                                   140,181
<INVENTORY>                                  1,602,143
<CURRENT-ASSETS>                            12,356,668
<PP&E>                                       4,297,827
<DEPRECIATION>                               3,575,981
<TOTAL-ASSETS>                              13,145,681
<CURRENT-LIABILITIES>                        2,349,552
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       221,536
<OTHER-SE>                                  10,341,796
<TOTAL-LIABILITY-AND-EQUITY>                13,145,681
<SALES>                                     20,015,690
<TOTAL-REVENUES>                            20,415,733
<CGS>                                        5,740,209
<TOTAL-COSTS>                               19,066,787
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                19,127
<INTEREST-EXPENSE>                             105,896
<INCOME-PRETAX>                              1,532,987
<INCOME-TAX>                                    52,612
<INCOME-CONTINUING>                          1,480,375
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,480,375
<EPS-BASIC>                                     0.07
<EPS-DILUTED>                                     0.06


</TABLE>
Document

Exhibit 10.1
FOURTH AMENDMENT


TO SECOND AMENDED & RESTATED CONSUMER FINANCING SERVICES AGREEMENT


Effective Date: March 31, 2021


WHEREAS, APX Group, Inc. (“Vivint” or “Company”) and Citizens Bank, N.A. (“Citizens” or “Supplier”, and together with Vivint, the “Parties”) entered into that certain Second Amended and Restated Consumer Financing Services Agreement dated as of May 31, 2017 (as amended, the “Agreement”);


WHEREAS, the Parties desire to amend the Agreement;


NOW, THEREFORE, for valid and adequate consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:
1.Swap Curve Adjustments. The reference in the second sentence of the defined term “Swap
Curve” to “as of the first day of each calendar month” is hereby deleted and replaced with the following new reference: “as of the 15th day of each calendar month (or, if the 15th day of a month is not feasible due to cycle time, then on the next business day of such month)”.


2.Except as explicitly set forth in this Fourth Amendment, the Agreement is not amended or modified hereby. Section references used herein are to sections of the Agreement. Defined terms used herein without definition shall have the meanings ascribed to them in the Agreement.


IN WITNESS WHEREOF, the Parties hereto have caused their names to be signed hereto by their respective officers thereunto duly authorized as of the date first written above.






									
	APX GROUP, INC.		CITIZENS BANK, N.A.
	/S/ Dale R. Gerard		/S/ Andrew Rostami
	Name: Dale R. Gerard		Name: Andrew Rostami
	Title: Chief Financial Officer		Title: President, Citizens Pay
#### The People of the State of New York, Respondent, v Salvatore Pistone, Appellant.

—Appeal by the defendant from a judgment of the Supreme Court, Kings County (Hellenbrand, J.), rendered February 23, 1982, convicting him of conspiracy in the second degree and conspiracy in the fourth degree, upon a jury verdict, and imposing sentence.

Judgment affirmed.

Prior to trial, the defendant had entered a plea of guilty to both counts of the indictment before Justice Feldman, who promised that the sentence imposed would be concurrent indeterminate terms of imprisonment of 1 to 3 years. This sentence promise was conditioned upon the sentence being found appropriate after a review of a presentence report and certain tapes that constituted evidence in the case. The record further discloses that thereafter the court could not adhere to the promised sentence based upon the information contained in the tapes and it determined that an appropriate sentence would be 7 to 21 years. The defendant’s subsequent motion to withdraw his plea of guilty was granted, his plea was vacated, and the case proceeded to trial.

We find that the court properly determined that it could not abide by its sentence promise. Accordingly, the defendant was appropriately given the opportunity to either accept the sen*825tence which the court deemed appropriate or withdraw his plea *(see, People v Grant,*99 AD2d 536). The defendant was not entitled to imposition of the original promised sentence *(see, People v Grant, supra; cf. People v Rogers,*56 NY2d 552; *People v Hamil,*110 AD2d 659). Gibbons, J. P., Brown, Lawrence and Kooper, JJ., concur.
Case: 1:02-cr-00444 Document #: 93 Filed: 01/29/03 Page 1 of 8 PageID #:335

Case: 1:02-cr-00444 Document #: 93 Filed: 01/29/03 Page 2 of 8 PageID #:336

Case: 1:02-cr-00444 Document #: 93 Filed: 01/29/03 Page 3 of 8 PageID #:337

Case: 1:02-cr-00444 Document #: 93 Filed: 01/29/03 Page 4 of 8 PageID #:338

Case: 1:02-cr-00444 Document #: 93 Filed: 01/29/03 Page 5 of 8 PageID #:339

Case: 1:02-cr-00444 Document #: 93 Filed: 01/29/03 Page 6 of 8 PageID #:340

Case: 1:02-cr-00444 Document #: 93 Filed: 01/29/03 Page 7 of 8 PageID #:341

Case: 1:02-cr-00444 Document #: 93 Filed: 01/29/03 Page 8 of 8 PageID #:342
Exhibit 31.2



CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO

SECURITIES EXCHANGE ACT RULES 13A-14 AND 15D-14



I, Stacy M. Riffe, Chief Financial Officer of the registrant, certify that:



1. I have reviewed this quarterly report on Form 10-Q of U.S. Restaurant Properties, Inc.



2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;



3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;



4. The registrants other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:



a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;



b) Evaluated the effectiveness of the registrants disclosure controls
and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and



c) Disclosed in this report any change in the registrants internal
control over financial reporting that occurred during the registrants most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and



5. The registrants other certifying officer and I have disclosed, based
on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons fulfilling the equivalent function):



a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and



b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrants internal control over financial reporting.



|                       
|-----------------------
|/s/ Stacy M. Riffe     
|Stacy M. Riffe         
|Chief Financial Officer
|                       
|Dated: May 10, 2004
Exhibit 13.2



Credicorp Ltd.



Certification Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002



(18 U.S.C. Section
1350)



Pursuant to the requirements
of Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Sections 1350(a) and (b)), the undersigned hereby certifies as follows:



I am the Chief Financial
Officer of Credicorp Ltd. (the “Company”).



| | 1. | To my knowledge:
| | -- | ----------------



| | (A) | The Company’s Annual Report on Form 20-F for the year ended December 31, 2013 accompanying
this Certification, in the form filed with the Securities and Exchange Commission (the “Report”), fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (B) | The information in the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company.
| | --- | ------------------------------------------------------------------------------------------------------------------------------------------





Dated: April 30,
2014



By: /S/ FERNANDO
DASSO



Name:	Fernando
Dasso



Title:	Chief Financial
Officer
Case: 1:01-cv-06992 Document #: 20 Filed: 03/08/02 Page 1 of 19 PageID #:118
Case: 1:01-cv-06992 Document #: 20 Filed: 03/08/02 Page 2 of 19 PageID #:119
Case: 1:01-cv-06992 Document #: 20 Filed: 03/08/02 Page 3 of 19 PageID #:120
Case: 1:01-cv-06992 Document #: 20 Filed: 03/08/02 Page 4 of 19 PageID #:121
Case: 1:01-cv-06992 Document #: 20 Filed: 03/08/02 Page 5 of 19 PageID #:122
Case: 1:01-cv-06992 Document #: 20 Filed: 03/08/02 Page 6 of 19 PageID #:123
Case: 1:01-cv-06992 Document #: 20 Filed: 03/08/02 Page 7 of 19 PageID #:124
Case: 1:01-cv-06992 Document #: 20 Filed: 03/08/02 Page 8 of 19 PageID #:125
Case: 1:01-cv-06992 Document #: 20 Filed: 03/08/02 Page 9 of 19 PageID #:126
Case: 1:01-cv-06992 Document #: 20 Filed: 03/08/02 Page 10 of 19 PageID #:127
Case: 1:01-cv-06992 Document #: 20 Filed: 03/08/02 Page 11 of 19 PageID #:128
Case: 1:01-cv-06992 Document #: 20 Filed: 03/08/02 Page 12 of 19 PageID #:129
Case: 1:01-cv-06992 Document #: 20 Filed: 03/08/02 Page 13 of 19 PageID #:130
Case: 1:01-cv-06992 Document #: 20 Filed: 03/08/02 Page 14 of 19 PageID #:131
Case: 1:01-cv-06992 Document #: 20 Filed: 03/08/02 Page 15 of 19 PageID #:132
Case: 1:01-cv-06992 Document #: 20 Filed: 03/08/02 Page 16 of 19 PageID #:133
Case: 1:01-cv-06992 Document #: 20 Filed: 03/08/02 Page 17 of 19 PageID #:134
Case: 1:01-cv-06992 Document #: 20 Filed: 03/08/02 Page 18 of 19 PageID #:135
Case: 1:01-cv-06992 Document #: 20 Filed: 03/08/02 Page 19 of 19 PageID #:136
II

105TH CONGRESS

1ST SESSION S. 1229

To provide for the conduct of a clinical trial concerning digital mammography.

IN THE SENATE OF THE UNITED STATES

SEPTEMBER 26, 1997

Mr. CAMPBELL introduced the following bill; which was read twice and

referred to the Committee on Labor and Human Resources

A BILL

To provide for the conduct of a clinical trial concerning

digital mammography.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. OFFICE OF RESEARCH ON WOMEN’S HEALTH

4 CLINICAL TRIAL OF DIGITAL MAMMOG5 RAPHY.

6 (a) IN GENERAL.—The Office of Research on Wom7 en’s Health, acting through the Assistant Secretary for

8 Health, shall award grants under this section for the con9 duct of a large-scale clinical trial of digital mammography.

10 (b) CONTRACT.—In carrying out subsection (a), the

11 Office of Research on Women’s Health shall enter into a
2

•S 1229 IS

1 contract with the Multi-Agency Consortium on Imaging

2 Technologies to Improve Women’s Health for the solicita3 tion, acceptance and processing of competitive grant appli4 cations.

5 (c) REQUIREMENTS.—In providing for the conduct of

6 a clinical trial under this section the Office of Research

7 on Women’s Health shall ensure that—

8 (1) at least 50,000 women are tested under this

9 study;

10 (2) at least 20 institutions are involved in the

11 testing; and

12 (3) at least 2,500 conventional and 2,500 digi13 tal mammographies will be conducted at each insti14 tution.

15 (d) AUTHORIZATION OF APPROPRIATIONS.—There is

16 authorized to be appropriated $20,000,000 to carry out

17 this section.

Æ
Case: 1:01-cv-08933 Document #: 62 Filed: 11/27/02 Page 1 of 4 PageID #:1114
Case: 1:01-cv-08933 Document #: 62 Filed: 11/27/02 Page 2 of 4 PageID #:1115
Case: 1:01-cv-08933 Document #: 62 Filed: 11/27/02 Page 3 of 4 PageID #:1116
Case: 1:01-cv-08933 Document #: 62 Filed: 11/27/02 Page 4 of 4 PageID #:1117